SCHEMBL5577527

SCHEMBL5577527

O=C(NCc1ccnc(N2CCCN(Cc3ccc(F)cc3)CC2)c1)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.54
▸ OPRK1 P41145 1/20 0.54
▸ KLKB1 P03952 1/20 0.49
▸ KLK1 P06870 1/20 0.49
▸ MCHR1 Q99705 4/20 0.48
▸ CXCR3 P49682 7/20 0.47
▸ HTR2A P28223 2/20 0.47
▸ HTR1A P08908 1/20 0.47
▸ DRD2 P14416 1/20 0.47
▸ DRD4 P21917 1/20 0.47
▸ HTR2C P28335 1/20 0.47
▸ SLC6A4 P31645 1/20 0.47
▸ HTR7 P34969 1/20 0.47
▸ DRD3 P35462 1/20 0.47
▸ TMEM97 Q5BJF2 1/20 0.47
▸ SIGMAR1 Q99720 1/20 0.47
▸ CHRM3 P20309 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CHRM1 P11229 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577616 0.96 KLKB1 (0.52) OPRM1OPRK1KLKB1KLK1CXCR3
SCHEMBL5577757 0.86 MCHR1 (0.49) MCHR1DRD2DRD4DRD3
SCHEMBL5577580 0.84 MAPT (0.62) MCHR1HTR2AHTR1ADRD2DRD4
SCHEMBL5577719 0.83 CHRM3 (0.55) MCHR1CXCR3HTR2AHTR1ADRD2
SCHEMBL5577406 0.83 MT-CO2 (0.47) OPRM1OPRK1KLKB1KLK1CHRM3
SCHEMBL5577317 0.82 GAA (0.51) MCHR1DRD2DRD4DRD3CHRM3
SCHEMBL5577690 0.81 CXCR3 (0.58) KLKB1KLK1CXCR3KCNH2HRH3
SCHEMBL5577898 0.81 CXCR3 (0.48) KLKB1KLK1CXCR3DRD2DRD4
SCHEMBL5577844 0.81 SCN10A (0.56) OPRM1OPRK1MCHR1CXCR3HTR2A
SCHEMBL5577738 0.80 OPRM1 (0.52) OPRM1OPRK1MCHR1CXCR3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-22 — — US disclosed
EP-1616862-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-01-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof HLA-DRB1, MIF, HLA-C OPRM1 584/4885OPRK1 353/4885KLKB1 2759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback